Hims & Hers Health, Inc (NYSE:HIMS) shares are trading lower Thursday after Hunterbrook issued a short report on the stock.
What Happened: Hunterbrook released a bearish report on Thursday, alleging Hims & Hers sells knockoff GLP-1 weight loss drugs and relies on a single supplier with previously unreported ties to fraud and bankruptcy.
Benzinga reached out to Hims & Hers Health for comment on the report and received a response from a spokesperson highlighting a post on the company’s commitment to customer safety and another post on how the company is delivering safe access ...